Thailand's FDA has approved seven major platforms (LINE MAN, Shopee, CP ALL, Bangkok Drugstore, and others) to offer telepharmacy services starting June 2026, enabling remote pharmaceutical consultation and medication sales. While expanding consumer access, the model threatens ~18,000 independent pharmacy SMEs—which already saw market share drop from 90% to 75% over five years—because chain pharmacies with economies of scale can leverage telemedicine more effectively. SMEs face crippling fixed costs (pharmacist salaries 50k–100k baht/month per store) and struggle to recruit staff, while the model has security gaps: video/chat consultations risk misidentification, delivery lacks temperature controls, and dangerous drugs could reach illegal channels.